Closed · DCT-DCT-26-001 · CFDA 95.005 · Discretionary

FY 2026 DRUG COURT TRAINING AND TECHNICAL ASSISTANCE COMPETITIVE COOPERATIVE AGREEMENT SOLICITATION

Federal grant opportunity posted by Office of National Drug Control Policy, cataloged on Grants.gov.

$6M-$6M
Award range
Closed
Status
August 27, 2026
Close date
1
Expected awards

The verdict

FY 2026 DRUG COURT TRAINING AND TECHNICAL ASSISTANCE COMPETITIVE COOPERATIVE AGREEMENT SOLICITATION is a closed discretionary listing from Office of National Drug Control Policy that offered $6,000,000 -- $6,000,000 across 1 expected award. Future funding cycles may be published under the same CFDA number. PlainGrants indexes 54 other opportunities from Office of National Drug Control Policy.

$6M-$6M
award range
Closed
application status
1
expected award
95.005
CFDA program

Recently closed NOFO

This listing closed on August 27, 2026. CFDA 95.005 may re-announce under a new opportunity number. Historical award band was $6,000,000 -- $6,000,000.

According to Grants.gov (extract vintage 2026-08-10), this record reflects the officially published listing. See methodology.

Deadline tracker

Application window closed

Closed August 27, 2026

Posted Jul 15 Closes Aug 27

Est. Total Funding

$6,000,000

Expected Awards

1

Instrument

Cooperative Agreement

Description

ONDCP’s Drug Court Training and Technical Assistance Cooperative Agreement supports training and technical assistance (TTA) to ensure access to evidence-based addiction treatment through drug courts, including when substance use disorder co-occurs with other mental healthconditions. ONDCP seeks to reduce drug use and its consequences through evidence-based treatment that leads to long-term recovery, and this cooperative agreement will support the President’s priorities by applying this to the criminal justice system. The purpose of this cooperative agreement is to: (1) educate, train, and produce materials to improve the implementation of evidence-based treatment to individuals with addiction, including when substance use disorder co-occurs with other mental health conditions; (2)decrease criminal justice costs and recidivism rates; and (3) improve access to evidence-based addiction treatment that includes medications for opioid use disorder through drug courts. The cooperative agreement recipient shall:• Use expert practitioners in the science of addiction and evidence-based addiction treatment, as well as integration of treatment into the criminal justice system.• Use licensed behavioral health practitioners.• Provide in-person training, online training, and jurisdiction-specific technical assistanceto a wide range of geographically distributed areas—including rural locations—at thestate, local, and tribal levels.• Ensure close alignment of all TTA materials with the Trump Administration’s policy priorities, including the 2026 National Drug Control Strategy; an evidence-based approach to treating addiction--to include FDA-approved medications for opioid use disorder--contingency management, and other evidence-based behavioral health modalities for other substance use disorders; naloxone distribution and naloxone training.• Designate and fund a research or academic organization to conduct an independent assessment of the effectiveness and impact of training and technical assistance conducted under this cooperative agreement. The independent study should involve data collectionfrom state, local, and tribal jurisdictions engaged in cooperative agreement recipient programming.

Nonprofit-only applicant desk · Law, Justice and Legal Services

The printed eligibility set for FY 2026 DRUG COURT TRAINING AND TECHNICAL ASS… is nonprofit-only (Nonprofits with 501(c)(3) status (other than IHEs)). Government, campus, and for-profit doors are absent from this NOFO row. The extract does not mark applicant cost-sharing as required. Instrument: Cooperative Agreement. Funding-activity code maps to Law, Justice and Legal Services (LJL). This eligibility-code string dominates the Office of National Drug Control Policy book (25 peers, 45% of 55).

Code 12
Nonprofits with 501(c)(3) status (other than IHEs)

Codes are Grants.gov eligibility category values from the extract vintage 2026-08-10. Confirm the full eligibility statement on the official listing or the Grants.gov eligibility reference.

Official Listing on Grants.gov

View full details, application forms, and submission instructions.

View on Grants.gov

Agency Contact

Lisa Newton Grantor Phone 202-395-6639

More from Office of National Drug Control Policy

Closed Closed September 6, 2026

Applied Drug Policy Research Experiences

View →

What to do next

FY 2026 DRUG COURT TRAINING AND TECHNICAL ASS… is closed; use the parent program and agency catalog for the next funding cycle.

  • Browse open federal opportunities in the same category when this listing is closed. Open opportunities
  • Look up CFDA 95.005 across all indexed listings before you commit to this opportunity alone. Eligibility finder
  • Compare award ranges across federal categories before you pick a single CFDA. All categories

Opportunity deadlines and eligibility change on Grants.gov; PlainGrants mirrors the extract and is not the submission system.

Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.

Read our methodology - how this data is sourced, computed, and verified.

Data sourced from the SAM.gov Assistance Listings and Grants.gov. See our methodology for details. Retrieved and formatted by PlainGrants